Skip to main content

LUXE PACK Monaco | 30 September to 2 October 2024

Have you heard about our new siliconization operation?

We are pleased to announce the opening of a siliconization line at our state-of-the-art Saint-Quentin Lamotte (SQLM) plant, which safeguards the integrity of sensitive, aggressive and viscous drug products.

 

What is siliconization?

Suzhou Dialogue 2024 | 27 to 29 August

SGD Pharma expands capacity of siliconized glass vials with the announcement of a new siliconization line at its Center of Excellence for Type I glass in France

SGD Pharma, Global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces the opening of a new siliconization operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant.

SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit

SGD Pharma, global primary glass packaging leader, has announced the appointment of Fabio Invernizzi as its new General Manager of its West BU.

SGD Pharma celebrates the renovation of its Saint-Quentin-Lamotte (SQLM) furnace No2

SGD Pharma marked the start of the New Year by celebrating the renovation of its Saint-Quentin-Lamotte (SQLM) furnace No2 with a lighting ceremony performed by our appointed Godmother, Vanessa Rade, in accordance with glassmaking tradition.

SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements

SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass packaging. CEO Olivier Rousseau explains that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to its commercial, innovation, industrial, sustainability, HR and M&A strategies.

Subscribe to